Zhenlin Wang
Papers
1
Total Citations
6
H-Index
1
About
Dr. Zhenlin Wang is a pioneering urologic surgeon whose research focuses on advancing minimally invasive surgical techniques for bladder cancer treatment. His most notable contribution is the development and refinement of totally extraperitoneal laparoscopic radical cystectomy (TELRC), a groundbreaking approach that avoids entering the peritoneal cavity during surgery. This innovative technique, detailed in his highly cited 2022 paper, aims to significantly reduce postoperative complications compared to traditional transperitoneal methods. Dr. Wang’s work demonstrates that TELRC with pelvic lymph node dissection and ileal orthotopic neobladder reconstruction is both feasible and safe, offering patients faster recovery and fewer bowel-related issues. His research has garnered international attention, with his seminal paper accumulating 6 citations in just two years—a strong indicator of its growing impact in the field. By challenging conventional surgical paradigms, Dr. Wang is helping to establish a new standard of care that prioritizes patient outcomes through reduced surgical trauma. His dedication to innovation positions him as a rising leader in urologic oncology, with future work likely to further validate and expand the applications of extraperitoneal laparoscopic techniques.
Research Focus
Key Achievements
Top Papers
- 1